Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years.
I 2013 hadde det en impact factor på 45,217. [ trenger referanse ] I tillegg til The Lancet finnes det en rekke subspesialiserte tidsskrifter fra Lancet Publishing Group: The Lancet Neurology ( nevrologi ), The Lancet Oncology ( onkologi ) og The Lancet Infectious Diseases ( infeksjonssykdommer ).
1. Nature, 376, 552. 2. Journal of Clinical Oncology, 202, 300.
Key Factor Analysis. Journal Impact IF Ranking. · In the Oncology research field, the Quartile of The Lancet Oncology is Q1. The Lancet Oncology has been ranked #3 over 331 related journals in the Oncology research category. The ranking percentile of The Lancet Oncology is around 99% in the field of Oncology. The Lancet Oncology. The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar.
LetPub Scientific Journal Selector (2018-2021), LANCET ONCOLOGY published in 2000, UNITED STATES.
Journal Impact Factor List 2020 ID Print-ISSN J. I. Factor Full Journal Title 1 - 0007-9235 - 292.278 - CA-A CANCER JOURNAL FOR CLINICIANS 2 - 0028-4793 - 74.699 - NEW ENGLAND JOURNAL OF MEDICINE 3 - 0000-0000 - 71.189 - Nature Reviews Materials 4 - 1474-1776 - 64.797 - NATURE REVIEWS DRUG DISCOVERY 5 - 0000-0000 - 60.392 - LANCET Lancet Infectious Diseases Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1473-3099.
The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres).
Abstract. av D Wang · 2018 · Citerat av 32 — necrosis factor receptor superfamily member 4 (OX40), OX40 ligand, T‑cell immunoglobulin and mucin‑domain‑containing 3 Lancet Oncol. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. The Lancet Oncology. 2007 av L Lind · 2018 · Citerat av 54 — BackgroundThe knowledge of the impact of cardiovascular risk factors at different ages has mainly been based on different studies performed av A Matikas · 2021 — In brief, patients with human epidermal growth factor receptor 2-negative BC and tumors larger than 20 mm were enrolled in Lancet Oncol.
Publication h5-index h5-median; 1. The New England Journal of Medicine: 328: 520: 2. The Lancet: 258: 415: 3.
Lobulär cancer
The Lancet Oncology IF is increased by a factor of 0.21 and approximate percentage change is 0.62% when compared to preceding year 2017, which shows a rising trend. The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and ac The Lancet Oncology is a monthly journal, with original research articles, reviews, commentaries, editorials, viewpoints, and news in clinical oncology. Journal Impact Factor Trends Impact Factor Trend 2000 - 2019 / 2020 Comparison of impact index for the last two years (2018 and 2017) IF of The Lancet Oncology is increased by a factor of 0.21 compared to 2017. Change in percentage is 0.62%.
ISSN: 14702045, 14745488. The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice. The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opini
33.752 Impact Factor.
Sista dag ansökan högskolan
2021-04-24
3. Clinical Cancer Research, 133, 177. 4. In the 2010 Journal Citation Reports, The Lancet's impact factor was ranked The Lancet Oncology (oncology), and The Lancet Infectious Diseases (infectious With an impact factor of 24.725, the journal ranks third out of 202 oncology journals worldwide, is the leading clinical research journal in oncology, and is in the The Lancet Oncology has an Impact Factor of 33.752®. The journal ranks fourth out of 244 oncology journals worldwide, and is the leading clinical oncology THE LANCET Oncology Vol 5 January 2004 http://oncology.thelancet.com. 37 clinicopathological factors documented during the first two Clinical impact of.
The Lancet Oncology | Citations: 24,861 | The Lancet Oncology is a monthly, review journal, with articles, viewpoints, news and reviews in oncology. | Read 1100 articles with impact on
The Lancet Oncology IF is increased by a factor of 0.21 and approximate percentage change is 0.62% when compared to preceding year 2017, which shows a rising trend. · The 2019-2020 I-faktoren of The Lancet Oncology is 33.752 The Lancet Oncology Key Factor Analysis · The 2018-2019 I-faktoren of The Lancet Oncology is 35.386 The Lancet Oncology Key Factor Analysis Other titles: Oncology Start year: 2000 Frequency: Monthly Country: England Language: English Topics: Neoplasms Publisher: London : Lancet Pub. Group, c2000- Impact Factor: 33.752 ℹ Impact Factor: 2019: 33.752 The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
The impact factor (IF) 2018 of The Lancet Oncology is 34.34, which is computed in 2019 as per it's definition.The Lancet Oncology IF is increased by a factor of 0.21 and approximate percentage change is 0.62% when compared to preceding year 2017, which shows a rising trend. The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly Other titles: Oncology Start year: 2000 Frequency: Monthly Country: England Language: English Topics: Neoplasms Publisher: London : Lancet Pub. Group, c2000- Impact Factor: 33.752 ℹ Impact Factor: 2019: 33.752 The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. Journal Citation Reports (Clarivate Analytics, 2020) 5-Year Impact Factor: 35.843 ℹ Five-Year Impact Factor: 2019: 35.843 18 rows The The Lancet Oncology Impact-Faktor IF 2020-2021 is 33.752. Impact-Faktor IF Analyse, Trend, Ranking & Vorhersage. 2021-04-13 The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric. Cites per document Year Value; 2021-04-15 The Lancet Oncology has a h-index of 274.